Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer

被引:18
作者
Xu, Jing [1 ]
Lu, Donghui [2 ]
Zhang, Li [1 ]
Li, Jian [1 ]
Sun, Guoping [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Med Oncol, Hefei, Anhui, Peoples R China
[2] 901st Hosp Joint Logist Support Force PLA, Departrnent Radiol, Hefei, Anhui, Peoples R China
来源
CANCER MEDICINE | 2019年 / 8卷 / 17期
基金
中国国家自然科学基金;
关键词
metastatic esophageal cancer; nomogram; palliative resection; radiation; SEER; survival; SURGICAL RESECTION; THERAPY; CARCINOMA;
D O I
10.1002/cam4.2609
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose We aimed to explore the value of palliative resection or radiation of primary tumor for metastatic esophageal cancer (EC) patients. Methods Surveillance, Epidemiology, and End Results database was used for identifying metastatic EC patients. The patients were divided into resection and nonresection groups. And patients without resection were divided into radiation and nonradiation groups. Propensity score matching (PSM) analyses were adopted to reduce the baseline differences between the groups. Cancer specific survivals (CSSs) and overall survivals (OSs) were compared by Kaplan-Meier (K-M) curves. Multivariable analyses by COX proportion hazards model were performed to identify risk factors for CSS and OS. Predictive nomograms were conducted according to both postoperative factors and preoperative factors. Results A total of 7982 metastatic EC patients were selected for our analyses. After PSM, 978 patients were included in the survival analyses comparing palliative resection and nonresection. The CSS and OS for patients underwent palliative resection were significantly longer than those without resection (median CSS: 21 months vs 7 months, P < .001; median OS: 20 months vs 7 months, P < .001). In the overall population without resection, 654 patients were matched for radiation and nonradiation groups. And K-M curves showed that patients with radiation had longer CSS and OS than those without radiation (median CSS: 11 months vs 6 months, P < .001; median OS: 10 months vs 6 months, P < .001). Nomograms were generated for prediction of 1-, 2-, and 3-year CSS and OS. All C-indexes implied moderate discrimination and accuracy. And all nomograms had good calibration. Conclusion Palliative resection or radiation of primary tumor could prolong CSS and OS of metastatic EC patients.
引用
收藏
页码:7253 / 7264
页数:12
相关论文
共 50 条
  • [21] Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors
    Ye, Hua
    Xu, Hong Liu
    Shen, Qijun
    Zheng, Qi
    Chen, Ping
    JOURNAL OF SURGICAL RESEARCH, 2019, 243 : 578 - 587
  • [22] Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen
    He, Wen-Zhuo
    Rong, Yu-Ming
    Jiang, Chang
    Liao, Fang-Xin
    Yin, Chen-Xi
    Guo, Gui-Fang
    Qiu, Hui-Juan
    Zhang, Bei
    Xia, Liang-Ping
    CHINESE JOURNAL OF CANCER, 2016, 35 : 58
  • [23] Effect of primary tumor resection on overall survival in patients with stage IV breast cancer
    Lim, Sung Mook
    Kim, Jee Ye
    Park, Hyung Seok
    Park, Seho
    Kim, Gun Min
    Sohn, Joohyuk
    Kim, Seung Il
    BREAST JOURNAL, 2019, 25 (05) : 908 - 915
  • [24] Survival Outcome and Optimal Candidates of Primary Tumor Resection for Patients With Metastatic Medullary Thyroid Cancer
    Liu, Chu-Qiao
    Shen, Cen-Kai
    Du, Yu-Xin
    Li, Zi-Meng
    Shi, Xiao
    Wang, Yu
    Wei, Wen-Jun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (11) : 2979 - 2985
  • [25] Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
    Ergun, Yakup
    Bal, Oznur
    Dogan, Mutlu
    Ucar, Gokhan
    Dirikoc, Merve
    Acikgoz, Yusuf
    Bacaksiz, Ferhat
    Uncu, Dogan
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
  • [26] Extended cancer-free survival after palliative chemoradiation for metastatic esophageal cancer
    Hideomi Yamashita
    Kae Okuma
    Akihiro Nomoto
    Mami Yamashita
    Hiroshi Igaki
    Keiichi Nakagawa
    World Journal of Gastrointestinal Oncology, 2014, (02) : 52 - 54
  • [27] Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis
    Zhang, Rong-xin
    Ma, Wen-juan
    Gu, Yu-ting
    Zhang, Tian-qi
    Huang, Zhi-mei
    Lu, Zhen-hai
    Gu, Yang-kui
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [28] Laparoscopic surgery for palliative resection of the primary tumor in incurable stage IV colorectal cancer
    Nishigori, Hideaki
    Ito, Masaaki
    Nishizawa, Yuji
    Kohyama, Atsushi
    Koda, Takamaru
    Nakajima, Kentaro
    Nishizawa, Yusuke
    Kobayashi, Akihiro
    Sugito, Masanori
    Saito, Norio
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2012, 26 (11): : 3201 - 3206
  • [29] The beneficial effect of palliative resection in metastatic colorectal cancer
    Park, J. H.
    Kim, T-Y
    Lee, K-H
    Han, S-W
    Oh, D-Y
    Im, S-A
    Kang, G. H.
    Chie, E. K.
    Ha, S. W.
    Jeong, S-Y
    Park, K. J.
    Park, J-G
    Kim, T-Y
    BRITISH JOURNAL OF CANCER, 2013, 108 (07) : 1425 - 1431
  • [30] Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival
    Turner, Natalie
    Tran, Ben
    Tran, Phillip V.
    Sinnathamby, Mathuranthakan
    Wong, Hui-Li
    Jones, Ian
    Croxford, Matthew
    Desai, Jayesh
    Tie, Jeanne
    Field, Kathryn Maree
    Kosmider, Suzanne
    Bae, Susie
    Gibbs, Peter
    CLINICAL COLORECTAL CANCER, 2015, 14 (03) : 185 - 191